Refining Lung Cancer Screening Criteria in the Era of Value-Based Medicine.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 28170392.
- Also identified by DOI 10.1371/journal.pmed.1002226 and PMC identifier 5295661.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In a Perspective on the Research Article by ten Haaf and colleagues, Steven Shapiro discusses the challenges of identifying screening strategies that maximize the number of cancers diagnosed, while minimizing the harms of overdiagnosis and maintaining cost-effectiveness.
Medical subject headings
- Cost-Benefit Analysis
- Early Detection of Cancer
- Mass Screening